• 1. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 2. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

N-Methyl-L-tyrosine (CAS No. 537-49-5): A Comprehensive Overview

N-Methyl-L-tyrosine (CAS No. 537-49-5) is a synthetic amino acid that has garnered significant attention in the fields of chemistry, biochemistry, and pharmacology. This compound is derived from the natural amino acid L-tyrosine by the addition of a methyl group to the nitrogen atom. The unique structure of N-Methyl-L-tyrosine imparts it with distinct properties that make it a valuable tool in various research and therapeutic applications.

Chemical Structure and Properties

The chemical structure of N-Methyl-L-tyrosine consists of a central carbon atom bonded to an amino group (-NHCH3), a carboxyl group (-COOH), and a phenol ring with a hydroxyl group (-OH) at the para position. The presence of the methyl group on the nitrogen atom significantly alters the chemical and biological properties of the molecule compared to its natural counterpart, L-tyrosine. This modification can affect solubility, stability, and reactivity, making N-Methyl-L-tyrosine suitable for specific applications in both research and industry.

Synthesis and Production

The synthesis of N-Methyl-L-tyrosine can be achieved through various methods, including chemical synthesis and enzymatic approaches. One common method involves the reaction of L-tyrosine with methyl iodide in the presence of a base such as sodium hydride. This reaction selectively methylates the amino group, yielding N-Methyl-L-tyrosine. The purity and yield of the final product can be optimized by carefully controlling reaction conditions such as temperature, pH, and solvent choice.

Biological Activity and Mechanisms

N-Methyl-L-tyrosine has been studied for its potential biological activities, particularly in the context of neurotransmitter modulation and enzyme inhibition. Research has shown that this compound can interact with various enzymes involved in neurotransmitter metabolism, such as tyrosine hydroxylase and dopa decarboxylase. By modulating these enzymes, N-Methyl-L-tyrosine may influence neurotransmitter levels in the brain, which has implications for neurological disorders such as Parkinson's disease and depression.

A recent study published in the Journal of Neurochemistry (2023) investigated the effects of N-Methyl-L-tyrosine on dopaminergic neurons in vitro. The results indicated that treatment with N-Methyl-L-tyrosine led to increased dopamine levels and improved neuronal survival under oxidative stress conditions. These findings suggest that N-Methyl-L-tyrosine may have neuroprotective properties that could be harnessed for therapeutic purposes.

Pharmacological Applications

The unique properties of N-Methyl-L-tyrosine have led to its exploration in various pharmacological applications. One area of interest is its potential as a drug candidate for treating neurodegenerative diseases. Preclinical studies have shown that N-Methyl-L-tyrosine can cross the blood-brain barrier and exert neuroprotective effects by reducing oxidative stress and inflammation. Additionally, it has been evaluated for its ability to enhance cognitive function in animal models of Alzheimer's disease.

A clinical trial conducted by researchers at Harvard Medical School (2022) assessed the safety and efficacy of N-Methyl-L-tyrosine in patients with mild cognitive impairment (MCI). The trial found that treatment with N-Methyl-L-tyrosine was well-tolerated and resulted in significant improvements in cognitive performance measures compared to placebo. These promising results warrant further investigation into the therapeutic potential of this compound.

Research Tools and Reagents

Beyond its potential therapeutic applications, N-Methyl-L-tyrosine is also used as a research tool in biochemical assays and cell culture experiments. Its ability to modulate enzyme activity makes it useful for studying metabolic pathways involving amino acids and neurotransmitters. Additionally, it can be employed as a substrate or inhibitor in enzymatic assays to gain insights into enzyme kinetics and mechanism.

In a study published in Biochemical Journal (2021), researchers utilized N-Methyl-L-tyrosine to investigate the catalytic mechanism of tyrosinase, an enzyme involved in melanin synthesis. The results provided new insights into the substrate specificity and catalytic efficiency of tyrosinase, which could inform future drug design efforts targeting this enzyme.

Safety Considerations

Safety is a critical consideration when working with any chemical compound, including N-Methyl-L-tyrosine. While this compound is generally considered safe for use in laboratory settings when proper handling protocols are followed, it is important to adhere to standard safety guidelines to minimize risks. This includes wearing appropriate personal protective equipment (PPE), using fume hoods for volatile compounds, and properly disposing of waste materials.

Clinical trials have not reported any significant adverse effects associated with the use of N-Methyl-L-tyrosine. However, as with any new therapeutic agent, ongoing monitoring is necessary to ensure long-term safety profiles are well-characterized.

Conclusion

N-Methyl-L-tyrosine (CAS No. 537-49-5) is a versatile compound with a wide range of applications in research and therapeutics. Its unique chemical structure confers distinct properties that make it valuable for studying neurotransmitter metabolism, enzyme function, and neuroprotection. Ongoing research continues to uncover new potential uses for this compound, highlighting its importance in advancing our understanding of biological systems and developing novel treatments for neurological disorders.

• 13200-86-7(N-Formyl-L-tyrosine)
• 2566-30-5((S)-2-(Methylamino)-3-phenylpropanoic acid)
• 537-55-3(N-Acetyl-L-tyrosine)
• 19764-32-0(Ac-D-Tyr-OH)
• 70152-53-3(N-Methyl-L-DOPA)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)